contrast reduction

Figure 1. Generation and use of a dynamic coronary roadmap during percutaneous coronary intervention

Original Contribution

Roadmap Fusion Imaging in Percutaneous Coronary Intervention Reduces Contrast Medium Exposure Irrespective of Investigator’s Experience Level

01/12/2024

Christine Quast, MD¹; Raphael Phinicarides, MD¹; Shazia Afzal, MD¹; Verena Veulemans, MD¹; Kathrin Klein, MD¹; Nora Berisha, MD¹; Pia Leuders, MD;¹ Ralf Erkens, MD¹; Christian Jung, MD¹; Florian Bönner, MD¹; Malte Kelm, MD^1,2; Amin Polzin, MD¹; Tobias Zeus, MD¹

Christine Quast, MD1; Raphael Phinica...

In this study, the authors aimed to determine if Dynamic Coronary Roadmap software is equally effective irrespective of the performing investigator’s experience level.

In this study, the authors aimed...

01/12/2024

Journal of Invasive Cardiology

Letter from the Editor

Use of the DyeVert System in Chronic Total Occlusion Percutaneous Coronary Intervention

08/27/2019

Peter Tajti, MD^1,2; Iosif Xenogiannis, MD¹; Allison Hall, MD¹; M. Nicholas Burke, MD¹; Ivan Chavez, MD¹; Santiago Garcia, MD¹; Mario Gössl, MD, PhD¹; Michael Mooney, MD¹; Anil Poulose, MD¹; Paul Sorajja, MD¹; Yale Wang, MD¹; Evangelia Vemmou, MD¹; Ilias Nikolakopoulos, MD¹; Pamela Morley, RN¹; Bavana V. Rangan, BDS, MPH¹; Imre Ungi, MD, PhD²; Emmanouil S. Brilakis, MD, PhD¹

Peter Tajti, MD1,2; Iosif Xenogianni...

CTO-PCI often requires administration of large contrast volume. The DyeVert system (Osprey Medical, Inc) is a device that interfaces with standard manifold systems to reduce the amount of contrast used. We compared the procedural outcomes of...

CTO-PCI often requires...

08/27/2019

Journal of Invasive Cardiology

Original Contribution

Contrast Minimization With the New-Generation DyeVert Plus System for Contrast Reduction and Real-Time Monitoring During Coronary and Peripheral Procedures: First Experience

07/25/2017

Nicola Corcione, MD^1,2*; Giuseppe Biondi-Zoccai, MD, MStat^3,4*; Paolo Ferraro, MD^1,2; Stefano Messina, MD^1,2; Gennaro Maresca, MD^1,2; Raffaella Avellino, BSc^1,2; Giovanni Napolitano, MD⁵; Elena Cavarretta, MD, PhD³; Arturo Giordano, MD, PhD^1,2

Nicola Corcione, MD1,2*; Giuseppe Bi...

Contrast-induced nephropathy remains the main adverse effect of contrast administration. We appraised the DyeVert Plus system inclusive of contrast reduction and real-time monitoring in a consecutive series of coronary or peripheral...

Contrast-induced nephropathy...

07/25/2017

Journal of Invasive Cardiology